|1.||Ratnaraj, Neville: 3 articles (05/2006 - 03/2005)|
|2.||Patsalos, Philip N: 3 articles (05/2006 - 03/2005)|
|3.||Luszczki, Jarogniew J: 3 articles (05/2006 - 03/2005)|
|4.||Czuczwar, Stanislaw J: 3 articles (05/2006 - 03/2005)|
|5.||Guscott, Martin R: 1 article (07/2006)|
|6.||Pike, Andrew: 1 article (07/2006)|
|7.||Hallett, David J: 1 article (07/2006)|
|8.||Reynolds, David S: 1 article (07/2006)|
|9.||Groves, James O: 1 article (07/2006)|
|10.||Wafford, Keith A: 1 article (07/2006)|
07/01/2006 - "However, loreclezole also failed to provide significant protection against PTZ-induced seizures in the beta2N265S mice. "
05/01/1991 - "The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations of 1-2 mg/l and 6/32 patients (19%) of the verum group experienced a seizure reduction of 50% or more. "
05/01/2004 - "Loreclezole (5 mg/kg) exerted a significant protective action against amygdala-kindled rats, reducing both seizure and afterdischarge (AD) durations. "
09/01/2003 - "Loreclezole (5 mg/kg) exerted a significant protective action in amygdala-kindled rats, reducing both seizure and afterdischarge durations. "
11/01/1992 - "20 microM loreclezole blocked the seizure like events in the entorhinal cortex completely 30-80 min after onset of application. "
11/01/1990 - "The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in rats."
11/01/1990 - "We report in this study that (1) consistent with the literature, pretreatment with diazepam (2.0-16.0 mg/kg i.p.) or scopolamine (3.0 mg/kg i.p.) produced impairment in passive avoidance performance of rats (anterograde amnesia), but (2) pretreatment with loreclezole (R 72063) (2.0-80.0 mg/kg i.p.) did not impair the acquisition, retention, or the retrieval (tested 18 h later) of passive avoidance behavior by rats at any dose. "
03/01/1991 - "Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. "
03/01/1991 - "Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients."
09/12/1994 - "To determine if anticonvulsant doses of loreclezole increase extracellular serotonin, we determined anticonvulsant dose-response relationships in genetically epilepsy-prone rats (GEPRs). "
03/01/1992 - "In animal models of epilepsy the anticonvulsant profile of loreclezole resembles that of barbiturates and benzodiazepines. "
01/01/2002 - "Not only new antiepileptic drugs, such as remacemide, loreclezole, lamotrigine, tiagabine, gabapentin, progabide and levetiracetam are evaluated, but also drugs used for other purposes, such as etomidate and fentanyl-fluanisone for anesthesia, opioidergic drugs and drugs used for strokes. "
|5.||Reflex Epilepsy (Photosensitive Epilepsy)
|7.||Cocaine (Cocaine HCl)